Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: A protocol for systematic review and meta-analysis

INTRODUCTION: Existing evidence on the difference in the incidence of tumor lysis syndrome (TLS) in Chronic Lymphocytic Leukemia (CLL) patients receiving novel therapies versus patients receiving conventional therapies is limited and inconclusive. The aims of this planned systematic review and meta-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Kassem, Nancy, Ghazy, Ahmed A., Abu-Tineh, Mohammad, Omar, Nabil E., Nashwan, Abdulqadir J., Chandra, Prem, Ghasoub, Rola, AbuTabar, Osama S., Yassin, Mohamed A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2020
Soggetti:
4800
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7748317/
https://ncbi.nlm.nih.gov/pubmed/33371096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000023632
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi